Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis

Yamamoto, M.; Sugimoto, T.

Clinical Calcium 24(9): 1379-1385

2014

ISSN/ISBN: 0917-5857
PMID: 25177011
Document Number: 12786
Bone metablism of glucocorticoid-induced osteopororsis (GIO) is characterised by transient increase in bone resorption and persistent suppression of bone formation caused by glucocorticoid. Teriparatide is an ideal drug for GIO, because of antagonistic effect against that pathophysiological conditions. Based on new findings of treatment for GIO around the world, teriparatide was selected as one of alternative drugs of the first line agents for GIO in revised version of the guidelines on the management and treatment of GIO of the Japanese Society for Bone and Mineral Research : 2014 update.

Document emailed within 1 workday
Secure & encrypted payments

Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis

Miki, T.; Okamoto, K. 2014: Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis Clinical Calcium 24(9): 1387-1392
Laroche, M.; Mazières, B. 1998: Beneficial effect of a thiazide diuretic on bone mineral density in male osteoporosis with hypercalciuria Clinical and Experimental Rheumatology 16(1): 109-110
Cortet, B.; Flipo, R.M.; Blanckaert, F.; Duquesnoy, B.; Marchandise, X.; Delcambre, B. 1997: Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy Revue du Rhumatisme 64(7-9): 451-458
Formiga, F.; Moga, I.; Navarro, M.A.; Nolla, J.M.; Bonnin, R.; Roig-Escofet, D.; Pujol, R. 1996: Bone mineral density in female patients with systemic lupus erythematosus treated with high glucocorticoid doses Revista Clinica Espanola 196(11): 747-750
Lange, U.; Boss, B.; Teichmann, J.; Stracke, H.; Neeck, G. 2000: Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica--a prospective study on the influence of glucocorticoid therapy Zeitschrift für Rheumatologie 59(Suppl 2): Ii/137-Ii/141
Benucci, M.; Dolenti, S.; Saviola, G.; Manfredi, M. 2006: Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate Recenti Progressi in Medicina 97(1): 24-27
Sone, T. 2005: Increase in bone mineral density and its effect on fracture risk Clinical Calcium 15(4): 625-629
Madsen, O.R. 2008: Bone mineral density and fracture risk in patients with ankylosing spondylitis Ugeskrift for Laeger 170(48): 3956-3960
Masaki, H.; Miki, T. 2006: Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP) Clinical Calcium 16(11): 1823-1832
Kaneko, K.; Kawai, S. 2014: Glucocorticoid and Bone. Significance of serum soluble RANKL measurement in patients under glucocorticoid therapy Clinical Calcium 24(9): 1361-1370
Aguilera-Barreiro, M.ía.d.l.A.; Rivera-Márquez, J.é A.; Trujillo-Arriaga, H.éc.M.; Ruiz-Acosta, J.M.; Rodríguez-García, M.E. 2013: Impact of risk factors for osteoporosis on bone mineral density in perimenopausal women of the City of Querétaro, México Archivos Latinoamericanos de Nutricion 63(1): 21-28
Lin, Z.-t.; Wang, T.-m.; Ge, J.-y.; Lin, H.; Zhu, X.-f. 2010: Analysis of mandibular bone mineral density of senile osteoporosis patients Zhonghua Kou Qiang Yi Xue Za Zhi 45(4): 214-218
Aujla, K.; Majithia, V. 2016: Assessment of Secondary Causes of Osteoporosis and Racial Differences in Men with Normal vs. Abnormal Bone Mineral Density in a Cohort of Men Undergoing Bone Mass Measurement Journal of the Mississippi State Medical Association 57(9): 285-288
Vania Padillavazquez, A.; Lamadridfigueroa, H.; Cruzvaldez, A. 2007: El peso, el porcentaje de grasa y la densidad minéral ósea materna son determinantes de la densidad minéral ósea en mujeres adolescentes y adultas jóvenes - Weight, fat percentage and maternal bone mineral density are determinants of bone mineral density in adolescent and young adult females Boletin Medico del Hospital Infantil de Mexico (Ed. Espanola) 64(2): 72-82
Radspieler, H.; Dambacher, M.A.; Kissling, R.; Neff, M. 2000: Is the amount of trabecular bone-loss dependent on bone mineral Density? a study performed by three centres of osteoporosis using high resolution peripheral quantitative computed tomography European Journal of Medical Research 5(1): 32-39
Trivitayaratana, W.; Trivitayaratana, P.; Kongkiatikul, S. 2001: Prediction of bone mineral density of lumbar spine, hip, femoral neck and Ward's triangle by forearm bone mineral density Journal of the Medical Association of Thailand 84(3): 390-396
Arboleya, L.R.; Morales, A.; Fiter, J. 2000: Effect of alendronate on bone mineral density and incidence of fractures in postmenopausal women with osteoporosis. A meta-analysis of published studies Medicina Clinica 114 Suppl. 2: 79-84
Osterman, T.; Laurén, L.; Kuurtamo, P.; Hannuniemi, R.; Isaksson, P.; Kippo, K.; Peng, Z.; Väänänen, H.K.; Sellman, R. 1998: The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats Journal of Pharmacology and Experimental Therapeutics 284(1): 312-316
Ribot, C.; Pouilles, J.M.; Tremollieres, F. 1995: Should we define osteoporosis based on bone mineral density criteria? Revue du Rhumatisme 62(9): 546-548
Grzanka, A.; Rogala, B. 2003: The effect of short-term and chronic glucocorticoid therapy on lymphocyte glucocorticoid receptor number in patients with asthma Archivum Immunologiae et Therapiae Experimentalis 51(5): 327-334